Axitinib multi target TKI

AG-013736 - AG013736 - AG 013736 - Inlyta      

pdf
pathology Benefit (demonstrated or suggested) and harm      
renal-cell carcinoma (advanced)

All results are NS for efficacy

meta-analysis